The high frequency of the fragile X premutation in the general population and its emerging neurocognitive implications highlight the need to investigate the effects of the premutation on lifespan cognitive development. Until recently, cognitive function in fragile X premutation carriers (fXPCs) was presumed to be unaffected by the mutation. Here we show that young adult female fXPCs show subtle, yet significant, age-and FMR1 gene mutation-modulated cognitive impairments as tested by a quantitative magnitude comparison task. Our results begin to define the neurocognitive endophenotype associated with the premutation in adults, who are at risk for developing a neurodegenerative disorder associated with the fragile X premutation. Results from the present study may potentially be applied toward the design of early interventions wherein we might be able to target premutation carriers most at risk for degeneration for preventive treatment.
a b s t r a c t
The high frequency of the fragile X premutation in the general population and its emerging neurocognitive implications highlight the need to investigate the effects of the premutation on lifespan cognitive development. Until recently, cognitive function in fragile X premutation carriers (fXPCs) was presumed to be unaffected by the mutation. Here we show that young adult female fXPCs show subtle, yet significant, age-and FMR1 gene mutation-modulated cognitive impairments as tested by a quantitative magnitude comparison task. Our results begin to define the neurocognitive endophenotype associated with the premutation in adults, who are at risk for developing a neurodegenerative disorder associated with the fragile X premutation. Results from the present study may potentially be applied toward the design of early interventions wherein we might be able to target premutation carriers most at risk for degeneration for preventive treatment.
Ó 2011 Elsevier Inc. All rights reserved.
Introduction
The fragile X premutation is defined by the presence of a CGG trinucleotide repeat expansion between $55 and 200 in the 5 0 untranslated region of the fragile X mental retardation 1 (FMR1) gene. Alleles in this CGG range produce a 3-8-fold increase in FMR1 mRNA levels in leukocytes and a decrease in FMR1 protein (FMRP) levels due to translational inefficiency of the mutant FMR1 mRNA (Tassone et al., 2000) . The full mutation, present in individuals having more than 200 CGG repeats, typically involves methylation, subsequent transcriptional silencing of the FMR1 gene, and lack of the FMR1 protein, FMRP (Fu et al., 1991; Pieretti et al., 1991; Snow et al., 1993; Verkerk et al., 1991; Yu et al., 1991) . The transcriptional silencing of the gene and the subsequent diminished or absent production of FMRP represents the biological basis for fragile X syndrome (FXS), which results in intellectual disability (Hagerman & Hagerman, 2004) , some aspects of which are now evident even in infancy (Farzin & Rivera, 2010 ).
In the general population, it is estimated that 1 in 260-813 males and 1 in 113-259 females are fragile X premutation carriers (fXPCs; Hagerman, 2008) . The fragile X premutation has important implications for multiple members of the same family. For example, a male fXPC will pass the premutation to all of his daughters. His daughters, depending upon their CGG repeat size, will have up to 50% risk of having a child with FXS (Bourgeois et al., 2009) . Recent studies suggest that the premutation alleles are associated with several psychiatric and clinical manifestations (Bourgeois et al., 2009) , with primary ovarian insufficiency, referred to as fragile X associated primary ovarian insufficiency (FXPOI) affecting 20-28% of women with an FMR1 premutation (FXPOI; Sullivan et al., 2005) and with the Fragile X Associated Tremor Ataxia Syndrome (FXTAS). FXTAS is a late-onset (>50 years old) neurodegenerative disorder that affects nearly 40% of male and 8% of female fXPCs (Jacquemont et al., 2004) and is associated with intention tremors, cerebellar gait ataxia, parkinsonism, and short term memory and executive function impairments (Bourgeois et al., 2009) .
The high frequency of the fragile X premutation in the general population and its emerging neurocognitive implications highlight the necessity of investigating the effects of the premutation on cognitive function, especially during adult development. There are relatively few studies conducted to date, especially in those 0278-2626/$ -see front matter Ó 2011 Elsevier Inc. All rights reserved. doi:10.1016/j.bandc.2011.01.001
